0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Joint Pain Injections Market Research Report 2023
Published Date: March 2023
|
Report Code: QYRE-Auto-21F7416
Home | Market Reports | Health| Health Conditions| Pain Management
Global Joint Pain Injections Market Insights Forecast to 2028
BUY CHAPTERS

Global Joint Pain Injections Market Research Report 2023

Code: QYRE-Auto-21F7416
Report
March 2023
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Joint Pain Injections Market

Based on injection type, the global joint pain injections market has been segmented into corticosteroid injections, hyaluronic acid injections, and others. In terms of joint type, the global joint pain injections market has been divided into knee & ankle, hip joint, shoulder & elbow, facet joints of the spine, and others. Based on distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies.
The global Joint Pain Injections market was valued at US$ 2768.5 million in 2022 and is anticipated to reach US$ 4013.6 million by 2029, witnessing a CAGR of 5.0% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Joint Pain Injections is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Joint Pain Injections is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Joint Pain Injections include Allergan, Pfizer, Sanofi, Anika Therapeutics, Ferring, Bioventus, Flexion Therapeutics, Zimmer Biomet Holdings and SEIKAGAKU CORPORATION, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Joint Pain Injections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Joint Pain Injections.
The Joint Pain Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Joint Pain Injections market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Joint Pain Injections manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Key Segmentations

By Company

  • Allergan
  • Pfizer
  • Sanofi
  • Anika Therapeutics
  • Ferring
  • Bioventus
  • Flexion Therapeutics
  • Zimmer Biomet Holdings
  • SEIKAGAKU CORPORATION
  • Chugai Pharmaceutical

Segment by Type

  • Corticosteroid Injections
  • Hyaluronic Acid Injections
  • Others

Segment by Application

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Consumption by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • U.A.E

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Joint Pain Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Joint Pain Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

Scope of Global Joint Pain Injections Market Report

Report MetricDetails
Report NameGlobal Joint Pain Injections Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Joint Pain Injections Market Overview
1.1 Product Overview and Scope of Joint Pain Injections
1.2 Joint Pain Injections Segment by Type
1.2.1 Global Joint Pain Injections Market Value Comparison by Type (2023-2029)
1.2.2 Corticosteroid Injections
1.2.3 Hyaluronic Acid Injections
1.2.4 Others
1.3 Joint Pain Injections Segment by Application
1.3.1 Global Joint Pain Injections Market Value by Application: (2023-2029)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Joint Pain Injections Market Size Estimates and Forecasts
1.4.1 Global Joint Pain Injections Revenue 2018-2029
1.4.2 Global Joint Pain Injections Sales 2018-2029
1.4.3 Global Joint Pain Injections Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Joint Pain Injections Market Competition by Manufacturers
2.1 Global Joint Pain Injections Sales Market Share by Manufacturers (2018-2023)
2.2 Global Joint Pain Injections Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Joint Pain Injections Average Price by Manufacturers (2018-2023)
2.4 Global Joint Pain Injections Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Joint Pain Injections, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Joint Pain Injections, Product Type & Application
2.7 Joint Pain Injections Market Competitive Situation and Trends
2.7.1 Joint Pain Injections Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Joint Pain Injections Players Market Share by Revenue
2.7.3 Global Joint Pain Injections Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Joint Pain Injections Retrospective Market Scenario by Region
3.1 Global Joint Pain Injections Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Joint Pain Injections Global Joint Pain Injections Sales by Region: 2018-2029
3.2.1 Global Joint Pain Injections Sales by Region: 2018-2023
3.2.2 Global Joint Pain Injections Sales by Region: 2024-2029
3.3 Global Joint Pain Injections Global Joint Pain Injections Revenue by Region: 2018-2029
3.3.1 Global Joint Pain Injections Revenue by Region: 2018-2023
3.3.2 Global Joint Pain Injections Revenue by Region: 2024-2029
3.4 North America Joint Pain Injections Market Facts & Figures by Country
3.4.1 North America Joint Pain Injections Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Joint Pain Injections Sales by Country (2018-2029)
3.4.3 North America Joint Pain Injections Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Joint Pain Injections Market Facts & Figures by Country
3.5.1 Europe Joint Pain Injections Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Joint Pain Injections Sales by Country (2018-2029)
3.5.3 Europe Joint Pain Injections Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Joint Pain Injections Market Facts & Figures by Country
3.6.1 Asia Pacific Joint Pain Injections Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Joint Pain Injections Sales by Country (2018-2029)
3.6.3 Asia Pacific Joint Pain Injections Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Joint Pain Injections Market Facts & Figures by Country
3.7.1 Latin America Joint Pain Injections Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Joint Pain Injections Sales by Country (2018-2029)
3.7.3 Latin America Joint Pain Injections Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Joint Pain Injections Market Facts & Figures by Country
3.8.1 Middle East and Africa Joint Pain Injections Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Joint Pain Injections Sales by Country (2018-2029)
3.8.3 Middle East and Africa Joint Pain Injections Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Joint Pain Injections Sales by Type (2018-2029)
4.1.1 Global Joint Pain Injections Sales by Type (2018-2023)
4.1.2 Global Joint Pain Injections Sales by Type (2024-2029)
4.1.3 Global Joint Pain Injections Sales Market Share by Type (2018-2029)
4.2 Global Joint Pain Injections Revenue by Type (2018-2029)
4.2.1 Global Joint Pain Injections Revenue by Type (2018-2023)
4.2.2 Global Joint Pain Injections Revenue by Type (2024-2029)
4.2.3 Global Joint Pain Injections Revenue Market Share by Type (2018-2029)
4.3 Global Joint Pain Injections Price by Type (2018-2029)
5 Segment by Application
5.1 Global Joint Pain Injections Sales by Application (2018-2029)
5.1.1 Global Joint Pain Injections Sales by Application (2018-2023)
5.1.2 Global Joint Pain Injections Sales by Application (2024-2029)
5.1.3 Global Joint Pain Injections Sales Market Share by Application (2018-2029)
5.2 Global Joint Pain Injections Revenue by Application (2018-2029)
5.2.1 Global Joint Pain Injections Revenue by Application (2018-2023)
5.2.2 Global Joint Pain Injections Revenue by Application (2024-2029)
5.2.3 Global Joint Pain Injections Revenue Market Share by Application (2018-2029)
5.3 Global Joint Pain Injections Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Joint Pain Injections Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Allergan Joint Pain Injections Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Joint Pain Injections Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Joint Pain Injections Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Joint Pain Injections Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi Joint Pain Injections Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Anika Therapeutics
6.4.1 Anika Therapeutics Corporation Information
6.4.2 Anika Therapeutics Description and Business Overview
6.4.3 Anika Therapeutics Joint Pain Injections Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Anika Therapeutics Joint Pain Injections Product Portfolio
6.4.5 Anika Therapeutics Recent Developments/Updates
6.5 Ferring
6.5.1 Ferring Corporation Information
6.5.2 Ferring Description and Business Overview
6.5.3 Ferring Joint Pain Injections Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Ferring Joint Pain Injections Product Portfolio
6.5.5 Ferring Recent Developments/Updates
6.6 Bioventus
6.6.1 Bioventus Corporation Information
6.6.2 Bioventus Description and Business Overview
6.6.3 Bioventus Joint Pain Injections Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bioventus Joint Pain Injections Product Portfolio
6.6.5 Bioventus Recent Developments/Updates
6.7 Flexion Therapeutics
6.6.1 Flexion Therapeutics Corporation Information
6.6.2 Flexion Therapeutics Description and Business Overview
6.6.3 Flexion Therapeutics Joint Pain Injections Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Flexion Therapeutics Joint Pain Injections Product Portfolio
6.7.5 Flexion Therapeutics Recent Developments/Updates
6.8 Zimmer Biomet Holdings
6.8.1 Zimmer Biomet Holdings Corporation Information
6.8.2 Zimmer Biomet Holdings Description and Business Overview
6.8.3 Zimmer Biomet Holdings Joint Pain Injections Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Zimmer Biomet Holdings Joint Pain Injections Product Portfolio
6.8.5 Zimmer Biomet Holdings Recent Developments/Updates
6.9 SEIKAGAKU CORPORATION
6.9.1 SEIKAGAKU CORPORATION Corporation Information
6.9.2 SEIKAGAKU CORPORATION Description and Business Overview
6.9.3 SEIKAGAKU CORPORATION Joint Pain Injections Sales, Revenue and Gross Margin (2018-2023)
6.9.4 SEIKAGAKU CORPORATION Joint Pain Injections Product Portfolio
6.9.5 SEIKAGAKU CORPORATION Recent Developments/Updates
6.10 Chugai Pharmaceutical
6.10.1 Chugai Pharmaceutical Corporation Information
6.10.2 Chugai Pharmaceutical Description and Business Overview
6.10.3 Chugai Pharmaceutical Joint Pain Injections Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Chugai Pharmaceutical Joint Pain Injections Product Portfolio
6.10.5 Chugai Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Joint Pain Injections Industry Chain Analysis
7.2 Joint Pain Injections Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Joint Pain Injections Production Mode & Process
7.4 Joint Pain Injections Sales and Marketing
7.4.1 Joint Pain Injections Sales Channels
7.4.2 Joint Pain Injections Distributors
7.5 Joint Pain Injections Customers
8 Joint Pain Injections Market Dynamics
8.1 Joint Pain Injections Industry Trends
8.2 Joint Pain Injections Market Drivers
8.3 Joint Pain Injections Market Challenges
8.4 Joint Pain Injections Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Joint Pain Injections Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Joint Pain Injections Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Joint Pain Injections Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Joint Pain Injections Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Joint Pain Injections Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Joint Pain Injections Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Joint Pain Injections Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Joint Pain Injections Average Price (USD/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Joint Pain Injections, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Joint Pain Injections, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Joint Pain Injections, Product Type & Application
    Table 12. Global Key Manufacturers of Joint Pain Injections, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Joint Pain Injections by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Joint Pain Injections as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Joint Pain Injections Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Joint Pain Injections Sales by Region (2018-2023) & (K Units)
    Table 18. Global Joint Pain Injections Sales Market Share by Region (2018-2023)
    Table 19. Global Joint Pain Injections Sales by Region (2024-2029) & (K Units)
    Table 20. Global Joint Pain Injections Sales Market Share by Region (2024-2029)
    Table 21. Global Joint Pain Injections Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Joint Pain Injections Revenue Market Share by Region (2018-2023)
    Table 23. Global Joint Pain Injections Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Joint Pain Injections Revenue Market Share by Region (2024-2029)
    Table 25. North America Joint Pain Injections Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Joint Pain Injections Sales by Country (2018-2023) & (K Units)
    Table 27. North America Joint Pain Injections Sales by Country (2024-2029) & (K Units)
    Table 28. North America Joint Pain Injections Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Joint Pain Injections Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Joint Pain Injections Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Joint Pain Injections Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Joint Pain Injections Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Joint Pain Injections Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Joint Pain Injections Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Joint Pain Injections Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Joint Pain Injections Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Joint Pain Injections Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Joint Pain Injections Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Joint Pain Injections Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Joint Pain Injections Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Joint Pain Injections Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Joint Pain Injections Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Joint Pain Injections Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Joint Pain Injections Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Joint Pain Injections Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Joint Pain Injections Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Joint Pain Injections Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Joint Pain Injections Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Joint Pain Injections Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Joint Pain Injections Sales (K Units) by Type (2018-2023)
    Table 51. Global Joint Pain Injections Sales (K Units) by Type (2024-2029)
    Table 52. Global Joint Pain Injections Sales Market Share by Type (2018-2023)
    Table 53. Global Joint Pain Injections Sales Market Share by Type (2024-2029)
    Table 54. Global Joint Pain Injections Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Joint Pain Injections Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Joint Pain Injections Revenue Market Share by Type (2018-2023)
    Table 57. Global Joint Pain Injections Revenue Market Share by Type (2024-2029)
    Table 58. Global Joint Pain Injections Price (USD/Unit) by Type (2018-2023)
    Table 59. Global Joint Pain Injections Price (USD/Unit) by Type (2024-2029)
    Table 60. Global Joint Pain Injections Sales (K Units) by Application (2018-2023)
    Table 61. Global Joint Pain Injections Sales (K Units) by Application (2024-2029)
    Table 62. Global Joint Pain Injections Sales Market Share by Application (2018-2023)
    Table 63. Global Joint Pain Injections Sales Market Share by Application (2024-2029)
    Table 64. Global Joint Pain Injections Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Joint Pain Injections Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Joint Pain Injections Revenue Market Share by Application (2018-2023)
    Table 67. Global Joint Pain Injections Revenue Market Share by Application (2024-2029)
    Table 68. Global Joint Pain Injections Price (USD/Unit) by Application (2018-2023)
    Table 69. Global Joint Pain Injections Price (USD/Unit) by Application (2024-2029)
    Table 70. Allergan Corporation Information
    Table 71. Allergan Description and Business Overview
    Table 72. Allergan Joint Pain Injections Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 73. Allergan Joint Pain Injections Product
    Table 74. Allergan Recent Developments/Updates
    Table 75. Pfizer Corporation Information
    Table 76. Pfizer Description and Business Overview
    Table 77. Pfizer Joint Pain Injections Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 78. Pfizer Joint Pain Injections Product
    Table 79. Pfizer Recent Developments/Updates
    Table 80. Sanofi Corporation Information
    Table 81. Sanofi Description and Business Overview
    Table 82. Sanofi Joint Pain Injections Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 83. Sanofi Joint Pain Injections Product
    Table 84. Sanofi Recent Developments/Updates
    Table 85. Anika Therapeutics Corporation Information
    Table 86. Anika Therapeutics Description and Business Overview
    Table 87. Anika Therapeutics Joint Pain Injections Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 88. Anika Therapeutics Joint Pain Injections Product
    Table 89. Anika Therapeutics Recent Developments/Updates
    Table 90. Ferring Corporation Information
    Table 91. Ferring Description and Business Overview
    Table 92. Ferring Joint Pain Injections Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 93. Ferring Joint Pain Injections Product
    Table 94. Ferring Recent Developments/Updates
    Table 95. Bioventus Corporation Information
    Table 96. Bioventus Description and Business Overview
    Table 97. Bioventus Joint Pain Injections Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 98. Bioventus Joint Pain Injections Product
    Table 99. Bioventus Recent Developments/Updates
    Table 100. Flexion Therapeutics Corporation Information
    Table 101. Flexion Therapeutics Description and Business Overview
    Table 102. Flexion Therapeutics Joint Pain Injections Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 103. Flexion Therapeutics Joint Pain Injections Product
    Table 104. Flexion Therapeutics Recent Developments/Updates
    Table 105. Zimmer Biomet Holdings Corporation Information
    Table 106. Zimmer Biomet Holdings Description and Business Overview
    Table 107. Zimmer Biomet Holdings Joint Pain Injections Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 108. Zimmer Biomet Holdings Joint Pain Injections Product
    Table 109. Zimmer Biomet Holdings Recent Developments/Updates
    Table 110. SEIKAGAKU CORPORATION Corporation Information
    Table 111. SEIKAGAKU CORPORATION Description and Business Overview
    Table 112. SEIKAGAKU CORPORATION Joint Pain Injections Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 113. SEIKAGAKU CORPORATION Joint Pain Injections Product
    Table 114. SEIKAGAKU CORPORATION Recent Developments/Updates
    Table 115. Chugai Pharmaceutical Corporation Information
    Table 116. Chugai Pharmaceutical Description and Business Overview
    Table 117. Chugai Pharmaceutical Joint Pain Injections Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 118. Chugai Pharmaceutical Joint Pain Injections Product
    Table 119. Chugai Pharmaceutical Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Joint Pain Injections Distributors List
    Table 123. Joint Pain Injections Customers List
    Table 124. Joint Pain Injections Market Trends
    Table 125. Joint Pain Injections Market Drivers
    Table 126. Joint Pain Injections Market Challenges
    Table 127. Joint Pain Injections Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Joint Pain Injections
    Figure 2. Global Joint Pain Injections Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Joint Pain Injections Market Share by Type in 2022 & 2029
    Figure 4. Corticosteroid Injections Product Picture
    Figure 5. Hyaluronic Acid Injections Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Joint Pain Injections Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Joint Pain Injections Market Share by Application in 2022 & 2029
    Figure 9. Hospital Pharmacies
    Figure 10. Retail Pharmacies
    Figure 11. Online Pharmacies
    Figure 12. Global Joint Pain Injections Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Joint Pain Injections Market Size (2018-2029) & (US$ Million)
    Figure 14. Global Joint Pain Injections Sales (2018-2029) & (K Units)
    Figure 15. Global Joint Pain Injections Average Price (USD/Unit) & (2018-2029)
    Figure 16. Joint Pain Injections Report Years Considered
    Figure 17. Joint Pain Injections Sales Share by Manufacturers in 2022
    Figure 18. Global Joint Pain Injections Revenue Share by Manufacturers in 2022
    Figure 19. The Global 5 and 10 Largest Joint Pain Injections Players: Market Share by Revenue in 2022
    Figure 20. Joint Pain Injections Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 21. Global Joint Pain Injections Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 22. North America Joint Pain Injections Sales Market Share by Country (2018-2029)
    Figure 23. North America Joint Pain Injections Revenue Market Share by Country (2018-2029)
    Figure 24. U.S. Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 25. Canada Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 26. Europe Joint Pain Injections Sales Market Share by Country (2018-2029)
    Figure 27. Europe Joint Pain Injections Revenue Market Share by Country (2018-2029)
    Figure 28. Germany Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. France Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. U.K. Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Italy Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Russia Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Asia Pacific Joint Pain Injections Sales Market Share by Region (2018-2029)
    Figure 34. Asia Pacific Joint Pain Injections Revenue Market Share by Region (2018-2029)
    Figure 35. China Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Japan Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. South Korea Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. India Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Australia Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Taiwan Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Indonesia Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Thailand Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Malaysia Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Philippines Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Latin America Joint Pain Injections Sales Market Share by Country (2018-2029)
    Figure 46. Latin America Joint Pain Injections Revenue Market Share by Country (2018-2029)
    Figure 47. Mexico Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Brazil Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Argentina Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Middle East & Africa Joint Pain Injections Sales Market Share by Country (2018-2029)
    Figure 51. Middle East & Africa Joint Pain Injections Revenue Market Share by Country (2018-2029)
    Figure 52. Turkey Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Saudi Arabia Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. U.A.E Joint Pain Injections Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 55. Global Sales Market Share of Joint Pain Injections by Type (2018-2029)
    Figure 56. Global Revenue Market Share of Joint Pain Injections by Type (2018-2029)
    Figure 57. Global Joint Pain Injections Price (USD/Unit) by Type (2018-2029)
    Figure 58. Global Sales Market Share of Joint Pain Injections by Application (2018-2029)
    Figure 59. Global Revenue Market Share of Joint Pain Injections by Application (2018-2029)
    Figure 60. Global Joint Pain Injections Price (USD/Unit) by Application (2018-2029)
    Figure 61. Joint Pain Injections Value Chain
    Figure 62. Joint Pain Injections Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS